Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer

Eur Urol. 2008 Nov;54(5):1106-7. doi: 10.1016/j.eururo.2007.11.035. Epub 2007 Nov 26.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • ADAM Proteins / biosynthesis
  • ADAM Proteins / genetics*
  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics*
  • Neoplasm Recurrence, Local / genetics*
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / pathology
  • Prognosis
  • Prostate-Specific Antigen / blood*
  • Prostatectomy
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / surgery
  • RNA, Neoplasm / genetics*

Substances

  • Biomarkers, Tumor
  • Membrane Proteins
  • RNA, Neoplasm
  • Prostate-Specific Antigen
  • ADAM Proteins
  • ADAM9 protein, human